2008•Yixue yanjiusheng xuebaoRequires access

Endothelin A receptor antagonist BQ123 inhibits the proliferation and induces the apoptosis of human prostate cancer cell line PC3

Wenquan Zhou

Open publisher page 0 citations

Abstract

Objective:To investigate the anti-tumor effect of the endothelin A receptor antagonist BQ123 on the human prostate cancer cell line PC3 in vitro by observing its impact on the proliferation and apoptosis of human prostate cancer cells.Methods:The inhibiting effect of BQ123 on the proliferation of PC3 cells was observed by MTT assay,erasion trace test and Traswell chamber chemotaxis assay,and its induction of their apoptosis determined by Annexin V-FITC/PI staining and flow cytometry.Results:BQ123 inhibited the migration and invasion abilities of PC3 cells in a dose-dependent manner and induced their apoptosis as well.Conclusion:BQ123 inhibits the proliferation of PC3 cells in a dose-dependent manner and induces their apoptosis in vitro,which has offered a new idea for the treatment of prostate cancer.

About this research paper

What this paper is about

Objective:To investigate the anti-tumor effect of the endothelin A receptor antagonist BQ123 on the human prostate cancer cell line PC3 in vitro by observing its impact on the proliferation and apoptosis of human prostate cancer cells.Methods:The inhibiting effect of BQ123 on the proliferation of PC3 cells was observed by MTT assay,erasion trace test and Traswell chamber chemotaxis assay,and its induction of their apoptosis determined by Annexin V-FITC/PI staining and flow cytometry.Results:BQ123 inhibited the migration and invasion abilities of PC3 cells in a dose-dependent manner and induced their apoptosis as well.Conclusion:BQ123 inhibits the proliferation of PC3 cells in a dose-dependent manner and induces their apoptosis in vitro,which has offered a new idea for the treatment of prostate cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the anti-tumor effect of the endothelin A receptor antagonist BQ123 on the human prostate cancer cell line PC3 in vitro by observing its impact on the proliferation and apoptosis of human prostate cancer cells.Methods:The inhibiting effect of BQ123 on the proliferation of PC3 cells was observed by MTT assay,erasion trace test and Traswell chamber chemotaxis assay,and its induction of their apoptosis determined by Annexin V-FITC/PI staining and flow cytometry.Results:BQ123 inhibited the migration and invasion abilities of PC3 cells in a dose-dependent manner and induced their apoptosis as well.Conclusion:BQ123 inhibits the proliferation of PC3 cells in a dose-dependent manner and induces their apoptosis in vitro,which has offered a new idea for the treatment of prostate cancer.

Key concepts: Apoptosis, Prostate cancer, Annexin, Flow cytometry, Cancer research, Cell growth, In vitro, MTT assay

Related papers

Back to paper searchBrowse research topicsOriginal source
Endothelin A receptor antagonist BQ123 inhibits the proliferation and induces the apoptosis of human prostate cancer cell line PC3 — Research Paper | ScholarLens